Bloom's syndrome (BS) is a rare autosomal recessive disorder characterized by pre-and postnatal growth deficiency, immunodeficiency, and a tremendous predisposition to a wide variety of cancers. Cells from BS individuals are characterized by a high incidence of chromosomal gaps and breaks, elevated sister chromatid exchange, quadriradial formations, and locus-specific mutations. BS is the consequence of mutations that lead to loss of function of BLM, a gene encoding a helicase with homology to the RecQ helicase family. To delineate the role of BLM in DNA replication, recombination, and repair we used a yeast two-hybrid screen to identify potential protein partners of the BLM helicase. The C terminus of BLM interacts directly with MLH1 in the yeast-two hybrid assay; far Western analysis and co-immunoprecipitations confirmed the interaction. Cell extracts deficient in BLM were competent for DNA mismatch repair. These data suggest that the BLM helicase and MLH1 function together in replication, recombination, or DNA repair events independent of single base mismatch repair.
Bloom's syndrome (BS) 1 is a rare autosomal recessive disorder characterized by immunodeficiency, short stature, male infertility, and an increased risk of a broad spectrum of cancers (1) . Cells isolated from BS individuals are characterized by cytogenetic abnormalities, with the hallmark feature of hyperrecombination between sister chromatids. BS chromosomes also display increased levels of breaks, translocations, quadriradial formations, and telomeric associations (2) .
The gene mutated in BS was positionally cloned and named BLM; it encodes a 1417-amino acid protein with strong homology to the Escherichia coli RecQ family of DNA and RNA helicases (3) . The E. coli RecQ helicase participates in homologous recombination and suppresses illegitimate recombination (4, 5) . Other eukaryotic RecQ family members include Sgs1p from Saccharomyces cerevisiae and Rqh1p from Schizosaccharomyces pombe; loss of function of either of these helicases results in genomic instability (6, 7) . Mutations in other human RecQ helicases result in the rare autosomal recessive disorders Werner's syndrome and Rothmund-Thomson syndrome, also characterized by chromosomal instability and cancer predisposition (8, 9) .
The BLM helicase unwinds duplex DNA from 3Ј to 5Ј in the presence of ATP (10, 11) . It also selectively recognizes and promotes branch migration of Holliday junctions in vitro (12) . BLM can be found in a large protein complex in the nucleus with other proteins involved in DNA repair such as BRCA1, ATM, MLH1, MSH2, MSH6, and replication factor C (13) . However, direct interactions of BLM have only been demonstrated biochemically with replication protein A (RPA) and topoisomerase III␣ (14 -16) . These experiments suggest that the BLM helicase interacts with a variety of nuclear proteins to perform functions in DNA replication, recombination, or repair.
To understand the role of the BLM helicase in maintaining genomic stability, a yeast two-hybrid screen was used to identify proteins that directly interact with BLM; the DNA mismatch repair protein MLH1 was identified. Far Western analysis and immunoprecipitations confirmed the direct interaction of these two proteins through the C terminus of BLM. In vitro assays did not demonstrate a role for BLM, however, in DNA mismatch repair. These data suggest that the BLM helicase and MLH1 may function cooperatively in maintaining genomic stability independent of DNA mismatch repair.
MATERIALS AND METHODS
Reagents and Enzymes-Restriction endonucleases and T4 DNA ligase were purchased from New England Biolabs. PCR was performed using Pwo polymerase from Roche Molecular Biochemicals. Oligonucleotides were synthesized on an Applied Biosystems synthesizer and DNA sequencing was performed at the University of Cincinnati DNA Core Laboratory. Plasmids were purified using Qiagen purification kits. In vitro transcription and translation (IVTT) reactions were performed using the Promega TNT-coupled rabbit reticulocyte lysate system. Radiolabeled [
35 S]methionine from PerkinElmer Life Sciences was used to label proteins. To detect BLM by Western blot, a polyclonal antibody to BLM was purchased from Novus. To immunoprecipitate BLM, goat polyclonal antibodies from Santa Cruz, both BLM-1 and 2, were used, while MLH1 Western analyses and immunoprecipitations were performed with monoclonal antibodies from PharMingen. An ␣-replication protein A 70-kDa subunit antibody (Ab-1) and protein A/G-agarose were purchased from Calbiochem.
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Technologies, Inc.). Other cell lines were purchased from ATCC. HeLa cells were cultured in 10% fetal bovine serum, RPMI 1640 medium (Life Technologies, Inc.). The human erythroleukemia cell line, K562, was cultured in 10% fetal bovine serum, Iscove's modified Dulbecco's medium. All cell lines were grown at 37°C and 5% CO 2 . Nuclear extracts were prepared according to the standard Dignam protocol (18) .
Expression Construct Generation and Characterization-BLM-pET constructs for protein expression were derived by PCR using the pOPRSVI-BLM construct as a template (19) . The pET30A-BLM-C construct was generated by PCR amplification with Pwo polymerase and cloning of BLM nucleotides 2931-3995 directionally with the EcoRI and BamHI sites present in the polylinker. The pET24D-BLM-C construct was generated by PCR amplification and cloning of BLM nucleotides 3063-4325 into the NcoI site in the polylinker. The pET24D-BLM-N (nucleotides 75-1838) and the pET24D-BLM-H (nucleotides1839 -3077) constructs were generated by PCR amplification of BLM and cloning into the NheI site. Full-length MLH1 was generated by PCR from the plasmid identified in the yeast two-hybrid screen and subsequently was cloned into the pRSETB plasmid. IVTT reactions were analyzed by Western analysis with antibodies specific for either BLM or MLH1. Products from IVTT reactions were also verified by immunoprecipitation.
Yeast Two-hybrid Screening-A yeast two-hybrid screen was performed using the Matchmaker Two-Hybrid System from CLONTECH. DNA encoding the C terminus of BLM (nucleotides 3108 -4319) was cloned into the pAS2 vector by PCR. The C terminus of BLM was used as bait to screen a human B-lymphocyte cDNA library also purchased from CLONTECH. Transformants were plated onto a trp Ϫ , leu Ϫ , his Ϫ plus 50 mM 3-AT plates. Plates were incubated at 30°C for 10 days, and the growth of the yeast was monitored. ␤-galactosidase assays for potential interacting clones were performed according to the instructions provided by CLONTECH Matchmaker Two-Hybrid system. Isolation and Renaturation of BLM-C-Blm-C protein was expressed from pET30A-BLM-C in E. coli BL21 (DE3) pLysS induced with 0.5 mM isopropyl-1-thiogalactopyranoside, collected by centrifugation, rapidly frozen, and stored at Ϫ80°C. All subsequent procedures were performed at 4°C. Cells were thawed and resuspended in ice-cold 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1 mM KCl supplemented with a bacterial protease inhibitor mixture (Sigma). Cells were passed through a French press once at 1,000 pounds/square inch. Cell lysates were centrifuged at 15,000 ϫ g for one h. Since the majority of the BLM-C protein resided in the insoluble fraction, the pellet was resuspended in His-binding buffer (5 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9) with 8 M urea, centrifuged as before, and passed through a 0.4-micron filter before application to a Ni(II)-agarose column (His-Bind Resin, Novagen). Protein was eluted with His-binding buffer containing 8 M urea and 250 mM imidazole. Fractions were separated by 15% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie blue to determine yield and purity. Fractions that were more than 80% pure were dialyzed in a stepwise fashion in 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 10% glycerol with decreasing amounts of urea to obtain soluble protein. Approximately 30% of the total protein remained in solution after removal of urea.
Far Western Analysis-Twenty-five g of purified BLM-C terminus protein was resolved by 15% SDS-PAGE. The protein was transferred to PVDF membrane (Millipore) in a transfer buffer at 90V for 1 h. The membrane was stained with Ponceau S to detect the protein, and this portion of the membrane was excised. The membrane and bound protein were blocked in 5% non-fat dry milk in Tris-buffered saline (TBS) for 1 h and incubated with 25 g of nuclear extracts for 1 h on ice. The membrane was washed four times with TBS-Tween 20 (0.1%), and the bound proteins were eluted by boiling in 1ϫ SDS-PAGE loading buffer. These samples were separated by SDS-PAGE, transferred to PVDF membrane, and probed with an ␣-MLH1 antibody (PharMingen) to detect MLH1.
IVTT Immunoprecipitations-IVTT (Promega) reactions with [ 35 S]methionine were performed with pET24D-BLM-C or pRSETB-MLH1 using purified DNA (Qiagen) according to the manufacturer's recommendations. Thirty l of each IVTT reaction was added to a total volume of 500 l of binding buffer (20 mM Tris, pH 7.5, 10% glycerol, 150 mM NaCl, 5 mM EDTA, 1 mM dithiothreitol, 0.1% Tween 20, 1 mM phenylmethylsulfonyl fluoride and mammalian protease inhibitors (Sigma)). Proteins were incubated for 1 h to allow binding before they were precleared with 25 l of protein A/G beads. Five g of primary antibody and 25 l of protein A/G were used in each reaction. The beads were washed four times with binding buffer and then boiled. Proteins were separated by 10% SDS-PAGE. The 35 S-labeled signal was intensified with Enhance (PerkinElmer Life Sciences-DuPont) following the instructions of the manufacturer.
Mixed Lysate Immunoprecipitations-Full-length human BLM cDNA with a hexahistidine tag at the 5Ј-end was cloned into the pFASTBAC-HTc vector purchased from Life Technologies, Inc. to create the plasmid pFASTBAC-HTc-BLM. Virus production for insect cell infection was performed according to the protocol provided by the BacTo-Bac Baculovirus Expression Systems (Life Technologies, Inc.). Insect cells (Sf21) were infected with the viral stock pFASTBAC-HTchBLM with a multiplicity of infection of 2. Infected insect cells were incubated at 30°C for 48 h and lysed in 50 mM Tris-HCl, pH 8.5, 5 mM 2-mercaptoethanol, 100 mM KCl, 1 mM phenylmethylsulfonyl fluoride, and 1% Nonidet P-40 at 4°C. Insoluble material was removed by centrifugation at 10,000 ϫ g for 30 min at 4°C. Insect cell lysates were mixed with K562 human cell nuclear extracts (NE), which contain MLH1. Equal volumes of insect cell and K562 NE were precleared with pansorbin A (Calbiochem). Either 10 g of ␣-MLH1 (PharMingen) or 10 g of ␣-BLM-1 (Santa Cruz) antibody was used to immunoprecipitate MLH1 or BLM, respectively. Fifty l of protein A/G-agarose was added, incubated for 1 h, and washed extensively with IP wash buffer (20 mM Tris-HCl, pH 8.0, 0.1 M NaCl, 1 mM EDTA, 1% Nonidet P-40). The precipitated proteins were eluted into 1ϫ SDS-PAGE buffer and separated by 10% SDS-PAGE. Western blot analysis was performed to detect the presence of BLM, MLH1, or replication protein A (70-kDa subunit) in the immunoprecipitates.
In Vivo Immunoprecipitations-Five mg of K562 NE was precleared with 50 l of protein A/G beads. Fifty g of BLM affinity-purified antibodies (Santa Cruz BLM-1 and -2) were added to the precleared K562 NE and rotated for 2 h at 4°C. One hundred fifty l of protein A/G-agarose beads was added to the mixture and rotated for an additional 2 h. The immunoprecipitates were washed with 1 ml of IP wash buffer four times. The precipitated proteins were eluted into 1ϫ SDS-PAGE buffer and separated by 8% SDS-PAGE. Western blot analysis was performed to detect BLM and MLH1.
Mismatch Repair Assay-Preparation of cell-free extracts and mismatched substrates and procedures for measuring mismatch repair were as described (20) . Heteroduplex substrates for repair studies contained the mismatch or unpaired base and a nick in the (Ϫ) strand at position Ϫ264 (3Ј-nicked substrate) or ϩ276 (5Ј-nicked substrate), where position ϩ1 is the first transcribed nucleotide of the lacZ␣ gene. Repair reactions (25 l) contained 30 mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (pH 7.8), 7 mM MgCl 2 , 200 M each CTP, GTP, UTP, 4 mM ATP, 100 M each dCTP, dATP, dGTP, dTTP, 40 mM creatine phosphate, 100 mg/ml creatine phosphokinase, 15 mM sodium phosphate (pH 7.5), 1 fmol of substrate DNA, and 50 g of extract proteins. Reactions were incubated for 15 min at 37°C. Substrate DNA was recovered and introduced into E. coli NR9162 (mutS) via electroporation and plated to score plaques as described (20) . Repair efficiency is expressed in percent as 100 ϫ (1 minus the ratio of the percentages of mixed bursts obtained from extract-treated and untreated samples).
RESULTS
To identify protein partners of the BLM helicase, cDNA segments encoding the N terminus, helicase domain and C terminus were cloned into a GAL4-yeast two-hybrid vector and used to screen a human B-lymphocyte cDNA library (Fig. 1A) . The C terminus of BLM, amino acids 1036 -1417, identified five clones, two of which contained a full-length cDNA encoding the DNA mismatch repair protein MLH1 (Fig. 1B) .
IVTT products were mixed and immunoprecipitated to investigate the interaction between BLM and MLH1. MLH1 is present when mixed with the C terminus of BLM and immunoprecipitated with an antibody specific for BLM (Fig. 2) . The C terminus of BLM is detectable when mixed with MLH1 and immunoprecipitated with an MLH1-specific antibody. The Nterminal and helicase domains of the BLM helicase were unable to co-precipitate with MLH1 (data not shown). These data provide further evidence that BLM and MLH1 interact in vitro through the C terminus of BLM.
To study this in vitro interaction, lysates from insect cells that expressed full-length BLM were mixed with lysates from the human erythroleukemia cell line K562. Immunoprecipitation with an ␣-MLH1 antibody, but not nonspecific IgG, immunoprecipitated BLM (Fig.3A) . Conversely, immunopre-cipitation with ␣-BLM antibody demonstrated that MLH1 is associated with BLM ( Fig 3B) . As a positive control, BLM was immunoprecipitated with ␣-BLM and probed for the replication protein A (RPA) 70-kDa subunit, a known protein partner of the BLM helicase (14) . RPA was detected in the ␣-BLM immunoprecipitation but not in the IgG control immunoprecipitates (Fig. 3C) .
Far Western assays were performed to confirm the in vitro interaction of the C terminus of BLM and MLH1. Protein induction studies in bacteria show that the C terminus of BLM was expressed at high levels in E. coli but was only present in the insoluble fraction (data not shown). The C terminus of BLM was consequently isolated under denaturing conditions using nickel chromatography and then slowly dialyzed into buffer. Purified fractions were analyzed by SDS-PAGE followed by Coomassie staining to identify several fractions that were more than 90% pure. Far Western assays then confirmed that the C terminus of BLM and MLH1 interact in vitro. Briefly, the C terminus of BLM was bound to PVDF membrane and incubated in nuclear extracts; bound proteins were eluted. Western blot analysis with an ␣-MLH1 antibody detected a 90-kDa band (as well as some smaller degradation products) that co-migrates with both the lysate control and IVTT MLH1 (Fig. 4) . Although high salt washes greatly diminished the interaction between the two proteins, membrane alone and membrane coated with a nonspecific protein, cytochrome c, did not bind MLH1 demonstrating the specificity of the BLM-MLH1 interaction. MLH1 was also expressed in vitro by IVTT and was capable of binding to the immobilized C terminus of BLM (Fig.  4) .
To test for in vivo interactions, K562 NE were used for immunoprecipitation with ␣-BLM or ␣-MLH1 antibodies. MLH1 was co-immunoprecipitated with BLM from K562 NE but was not present in the IgG control immunoprecipitates (Fig. 5) . Endogenous BLM could not be detected when lysates were immunoprecipitated with antibodies that recognize MLH1. This may be due to the low expression levels of BLM in this cell line, its cell cycle-specific regulation, or the binding affinity of the BLM antibodies. It should be noted that Wang et al. have immunoprecipitated MLH1 and identified BLM, although the reverse experiment was not performed (13) .
Finally, the functional significance of the interaction between BLM and MLH1 was tested by examining the ability of BS cell extracts to carry out DNA mismatch repair by measuring their ability to repair mispaired substrates in vitro. M13mp2 DNA was used as a repair substrate and contained a covalently closed (ϩ) strand and a (Ϫ) strand with a nick (to direct repair to this strand) located several hundred base pairs away from the mispair in the lacZ␣ complementation gene. The (ϩ) strand encodes one plaque phenotype (either colorless or blue) and the (Ϫ) strand encodes another plaque phenotype. If the unrepaired heteroduplex is introduced into an E. coli strain deficient in methyl-directed mismatch repair, plaques will have a mixed phenotype due to expression of both strands. However, repair in a repair-proficient human cell extract will reduce the percentage of mixed plaques and increase the ratio of the (ϩ) strand phenotype relative to that of the (Ϫ) strand phenotype as the nick directs repair to the (Ϫ) strand.
BS cell extracts repair a G-G mispair as efficiently as a HeLa cell extract, which is repair proficient (Fig. 6A) . Repair is observed regardless of whether the nick is 3Ј or 5Ј to the mismatch, consistent with the bi-directional repair capability of the human mismatch repair system. The change in the ratio of blue to colorless plaques (Fig. 6B) indicates that repair is specific for the minus strand as directed by the nick in that strand. The BS extract also repairs substrates containing an A-C mismatch or either of two different unrepaired nucleotides. In contrast to these results, extracts of cell lines exhibiting microsatellite instability and having mutations in any of four mismatch repair genes (hMSH2, GTBP, MLH1, or PMS2) are uniformly deficient in strand-specific mismatch repair (data not shown). These results suggest that BLM does not directly function in the mismatch repair pathway but may play crucial roles in the processing of heteroduplex formations during replication, recombination, or other types of DNA repair. between MLH1 and the C terminus of BLM. Finally, mixed lysate immunoprecipitation with cells over-expressing fulllength BLM and in vivo immunoprecipitations confirmed the interaction. Our results demonstrate that MLH1 is a protein partner of the BLM helicase in addition to topoisomerase III␣ and replication protein A (14 -16) . In vitro DNA mismatch repair assays were performed to determine whether the BLM helicase is necessary for DNA mismatch repair. Cell extracts lacking functional BLM helicase activity were competent for DNA mismatch repair. These data suggest that the BLM/ MLH1 interaction may be important for specific DNA repair events independent of the repair of single DNA mismatches.
The BLM helicase is implicated in DNA replication, recombination, and/or repair. The primary defect leading to hyperrecombination in BS cells may be due to improper processing of DNA intermediates at stalled replication forks during DNA synthesis (21) (22) (23) . These stalled forks can result in double strand breaks if they are not correctly handled by cellular DNA repair machinery. It is unclear exactly how the BLM helicase resolves stalled replication forks, but double strand break repair via homologous or non-homologous recombination may be one explanation (24) . BLM may also recognize loops of di-and tri-nucleotide repeats generated by DNA replication due to polymerase slippage or by single-stranded annealing events occurring during gene conversion (25) . BLM may untangle these loops for mismatch repair complexes to process them efficiently.
Experiments using yeast mutants of sgs1, the S. cerevisiae homologue of BLM and WRN, and the mismatch repair gene msh2 may also provide clues to the functional significance of the BLM-MLH1 interaction (26) . sgs 1 mutation does not affect base substitution or frameshift mutation rates but increases gross chromosomal rearrangements. The mutation of both sgs1 and msh2 synergistically increases gross chromosomal rearrangements as well as homeologous recombination rates, suggesting that these proteins act in overlapping pathways to maintain genomic stability. Complexes containing BLM, MLH1, MSH2, and MSH6 have been identified using mass spectrometry (13) suggesting common functional roles for these proteins. MSH2-MSH6 could function by directing BLM via MLH1 to Holliday junctions (27) since BLM can resolve these structures in vitro (12) .
MLH1-MLH3 and MSH4-MSH5 also play crucial roles in recombination, although the exact functions of these proteins are not well defined (28, 29) . Complexed proteins like MLH1-MLH3 could act as sensors for recombination intermediates and possibly direct the BLM helicase to resolve these intermediates. Future studies will determine the mechanism by which mismatch repair complexes and the BLM helicase function to maintain genomic stability.
